Pivotal Immune-Bridging Study of the Inactivated Whole-Virus COVID-19 Vaccine VLA2001: A Phase 3, Randomized Controlled Clinical Trial in Adults Using Adenoviral Vector Vaccine AZD1222 as a Comparator

Rajeka Lazarus, Benedicte Querton, Irena Corbic, Juan Carlos Jaramillo,Katrin Dubischar, Michael Krammer,Petronela Weisova,Romana Hochreiter,Susanne Eder-Lingelbach,Christian Taucher,Adam Finn

SSRN Electronic Journal(2022)

引用 0|浏览3
暂无评分
关键词
adenoviral vector vaccine azd1222,immune-bridging,whole-virus
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要